Letters

Safety of thalidomide

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6948.193c (Published 16 July 1994) Cite this as: BMJ 1994;309:193
  1. S Asscher
  1. St George's Hospital Medical School, London SW17 0RE.

    EDITOR, - C L Crawford has raised some questions about the prescription of thalidomide on a named patient basis to patients with leprosy in Britain.1 He wrote to me when I was chairman of the Committee on the Safety of Medicines to ask what information a supplier is required by law to provide with thalidomide when supplying the drug to …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe